Shanchun Guo

Title: Innovations and Contributions of Inventor Shanchun Guo

Introduction

Shanchun Guo is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Guo's work focuses on developing effective therapies for proliferative diseases, particularly cancer.

Latest Patents

Guo's latest patents include "Inhibitors of androgen receptor signaling" and "Boronic derivatives of hydroxamates as anticancer agents." The first patent relates to androgen receptor signaling inhibitors and their synthesis. This invention aims to utilize these inhibitors in treating proliferative diseases, including prostate cancer, especially in cases of castration-resistant prostate cancer. The second patent discusses boronic derivatives of hydroxamate compounds, detailing methods for their production and use as monotherapy or in combination with other therapeutic agents for cancer treatment. This patent also highlights the potential of these compounds as epigenetic therapy medications, offering enhanced bioavailability, lower toxicity, and longer-lasting efficacy.

Career Highlights

Shanchun Guo is affiliated with Xavier University of Louisiana, where he conducts his research and development work. His academic and professional background has equipped him with the knowledge and skills necessary to innovate in the field of cancer therapeutics.

Collaborations

Guo collaborates with esteemed colleagues such as Guangdi Wang and Jiawang Liu. Their combined expertise contributes to the advancement of research in cancer treatment and the development of new therapeutic agents.

Conclusion

Shanchun Guo's innovative work and patents reflect his commitment to improving cancer treatment options. His contributions are vital in the ongoing fight against proliferative diseases, showcasing the importance of research and innovation in healthcare.